UVA researchers develop a new experimental approach to target glioblastoma

UVA researchers develop a new experimental approach to target glioblastoma

University of Virginia Comprehensive Cancer Center scientists have developed a promising new experimental approach to targeting glioblastoma, the most common and deadliest brain cancer.

Targeting Mitotic Kinesin KIF20A: A Differentiation-Based Therapeutic Strategy for Glioblastoma Stem/Progenitor Cells

Researchers investigated the therapeutic potential of targeting mitotic kinesin KIF20A in glioblastom stem/progenitor cells. KIF20A is a crucial component of cytokinetic machinery and cooperates with a network of cell fate regulators to balance proliferative and differentiative divisions in neural stem/progenitor cells. [Stem Cell Reports] Full Article

Focused Ultrasound Delivers miRNA to Treat Glioblastoma

Researchers developed a novel therapeutic approach to combat glioblastoma, the deadliest primary brain cancer.